Jiangsu Quan Xin Biomedical Co.
Latest round
- Series C
Last raised
- Mar 2022
Total raised
- Undisclosed
Investors
- 11
About Jiangsu Quan Xin Biomedical Co.
, Ltd. operates as an antibody drug developer, focusing on the treatment of autoimmune diseases. It established clinical development center in Beijing and Shanghai. The company has over 80 domestic and foreign patents. The founder and chairman of the company, Jiwan Qiu graduated from Zhejiang University and has working experience in biotechnology and pharmaceutical industry. The COO of the company, Jianwei Li graduated from University of Bern and has worked in SymyxTechnologiesInc. and Allergan,Inc., Ltd. was listed on the Hong Kong Stock Exchange. The company focuses on the research and development of biopharmaceuticals for autoimmune and allergic diseases. There are 9 product pipelines under research, including 1 drug that has been accepted by BLA. The medicines produced by the company include monoclonal analogues and innovative monoclonal antibodies. The products include QX002N, QX004N, QX005N, and QX008N. QX004N is suitable for psoriasis and Crohn's disease. The medicines can be used in curing immune disorders such as skin, rheumatism, respiratory and digestive diseases.38 million. The company used the proceeds from the listing for clinical trials.
Who invested in Jiangsu Quan Xin Biomedical Co.
11 investors across 5 rounds
See all investors in Jiangsu Quan Xin Biomedical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiangsu Quan Xin Biomedical Co.
Who invested in Jiangsu Quan Xin Biomedical Co.?
Jiangsu Quan Xin Biomedical Co. has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiangsu Quan Xin Biomedical Co. raised?
Jiangsu Quan Xin Biomedical Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiangsu Quan Xin Biomedical Co. last raise money?
Jiangsu Quan Xin Biomedical Co.'s most recent round on record is a Series C, in Mar 2022.
What does Jiangsu Quan Xin Biomedical Co. do?
Jiangsu Quan Xin Biomedical Co. is a biotechnology company.
Where is Jiangsu Quan Xin Biomedical Co. headquartered?
Jiangsu Quan Xin Biomedical Co. is headquartered in Taizhou, China.
Which VCs invest in companies like Jiangsu Quan Xin Biomedical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jiangsu Quan Xin Biomedical Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Jiangsu Quan Xin Biomedical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.